Kadcyla 100mg Injection consists of the active ingredient Ado-Trastuzumab emtansine. It is a prescription medication used to treat HER2-positive breast cancer that has spread to other parts of the body or has not responded to other treatments. It is a combination of two drugs: trastuzumab, which is an antibody that targets HER2 receptors, and emtansine, which is a chemotherapy drug that kills cancer cells. It is indicated to treat breast cancer in the early stages as well as advanced stages, where patients develop recurrence within six months of chemotherapy treatment. This medication acts against tumors that produce more than the normal amount of a certain protein (known as the HER2 protein).

Patients with residual breast cancer after chemotherapy treatment and HER2-targeted therapy have a poorer prognosis than those with no residual cancer. Report to your physician immediately if you experience side effects such as allergic reactions, unusual bleeding, etc. This medication does not show any adverse effects on the kidney. In rare cases, an infusion reaction is seen. Like all other medications, it shows mild side effects like nausea, vomiting, diarrhea, and hair loss.

• Advanced and metastatic breast cancer.
• Metastatic gastric cancer.

Ado-Trastuzumab emtansine works by combining the targeting ability of trastuzumab, which binds to HER2-positive cancer cells, with the cell-killing effects of emtansine, a chemotherapy drug. Once this medication binds to the HER2-positive cancer cells, it releases emtansine, which then enters the cancer cells and destroys them. This process helps to slow down or stop the growth of cancer, reducing the size of tumors and potentially extending the patient's life.

Kadcyla 100mg Injection is administered by a healthcare professional in a hospital or clinic setting. The dose and frequency depend on several factors, such as the individual's age, weight, overall health, and the type and stage of the cancer being treated.

Serious:

Infusion reactions, including fever, chills, rash, or difficulty breathing

Lung problems, including shortness of breath, cough, or fever

Heart problems, including heart failure or abnormal heart rhythms

Severe bleeding or bruising

Nerve damage, including numbness, tingling, or weakness

Severe allergic reactions

Common:

Fatigue

Nausea

Constipation

Muscle or joint pain

Headache

Fever

Low platelet count

High liver enzyme levels

Low red blood cell count

Loss of appetite

Rash or itching

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Kadcyla 100mg and cause undesirable side effects.

• Kadcyla 100mg Injection should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).
• Protected from light.
• Keep it in its original packaging until it is ready to be used.
• Keep reaching out of the reach of children and pets.
• It should be disposed of properly.

If you are receiving Kadcyla 100mg Injection, it's important to be proactive in managing your treatment and monitoring your symptoms. Keep communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Use effective birth control during the treatment and at least 7 weeks after the last dose. Immediately contact your healthcare provider in case of any worsening of symptoms or infusion reactions. Take steps to care for yourself physically and emotionally during treatment, and seek support from loved ones and professionals as needed. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. Being informed and engaged in your treatment can help ensure the best possible outcomes and manage potential risks or complications.